TARO   $42.96  -0.09% Market Closed

Taro Pharmaceutical Industries Ltd
Total Cash 879.35M
totalCashPerShare 23.396
EBITDA 38.40M
Total Debt 0.00
quickRatio 3.042
currentRatio 3.609
Total Revenue 629.18M
debtToEquity
Revenue/Share 16.74
ROA 0.00213
ROE 0.030569999
grossProfits
freeCashflow 21.04M
operatingCashflow 124.56M
earningsGrowth 1.18
revenueGrowth 0.125
grossMargins 0.48472
ebitdaMargins 0.06103
operatingMargins 0.059320003
profitMargins 0.08561
enterpriseValue 735.67M
forwardPE
floatShares 8.09M
sharesOutstanding 37.58M
sharesShort 73.56K
sharesShortPriorMonth 47.18K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.78%
heldPercentInstitutions 0.13%
Short Ratio help_outline 3.20%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 47.705
Price To Book help_outline 0.90
earningsQuarterlyGrowth 1.18
netIncomeToCommon 53.87M
trailingEps 1.43%
forwardEps 4.39%
enterpriseToEbitda 19.16
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 145
lastUpdated Aug. 18, 2024, 12:33 p.m.